News

October 12, 2022 PharmaCielo’s own CFO and board member, Ian Atacan, is on the panel discussing key challenges and opportunities for the global cannabis industry. Watch it today!  https://direc.to/iU_T

October 12, 2022 This is PharmaCielo’s second pharmaceutical grade product shipment to a well-established Latin American pharmaceutical company with operations in Uruguay. TORONTO, Canada and RIONEGRO, Colombia (October 12, 2022) – PharmaCielo Ltd. (“PharmaCielo” orthe “Company”) (TSXV: PCLO, OTCQX: PCLOF), the Canadian parent of Colombia’s

September 15, 2022 Shipment made to an established pharmaceutical distributor and clinical research organization in the Czech Republic, focused on medicinal grade cannabinoids. TORONTO, Canada and RIONEGRO, Colombia Colombia (September 15, 2022) – PharmaCielo Ltd. (“PharmaCielo” or the “Company”) (TSXV: PCLO,OTCQX: PCLOF), the Canadian parent

September 14, 2022 Colombian government has maintained its commitment to supporting its cannabis producers and building a dominant global export industry. Five tonne quota to grow THC-dominant cannabis strains for export as dried flower will support the fulfillment of current sales agreements, beginning in early

August 30, 2022 The Company continues to grow sales and expects to build momentum through the remainder of 2022 and through 2023, with recent progress in Israel, Brazil and Mexico. PharmaCielo product has been sold in 14 countries to date, and the Company expects to

August 25, 2022 The Company expects to begin exporting dried flower to Israel in early 2023. Israel is one of the largest importers of medical cannabis in the world, with 109,352 active medical patients in 2021 (+35% vs. 2020). TORONTO, Canada and RIONEGRO, Colombia (August

August 4, 2022 The Company has made a pre-commercial shipment of CBD isolate to its Mexican joint venture, to support product development by a Mexican phytotherapeutic company. TORONTO, Canada and RIONEGRO, Colombia (August 4, 2022) – PharmaCielo Ltd. (“PharmaCielo” orthe “Company”) (TSXV: PCLO, OTCQX: PCLOF),

July 28, 2022 TORONTO, Canada and RIONEGRO, Colombia (July 28, 2022) – PharmaCielo Ltd. (“PharmaCielo” or the“Company”) (TSXV: PCLO, OTCQX: PCLOF), the Canadian parent of Colombia’s premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S. ("Holdings"), today announced a

June 6, 2022 The Company has shipped pre-commercial quantities of CBD full spectrum oil containing THC, to support the development of a full spectrum product for the Brazilian market. TORONTO, Canada and RIONEGRO, Colombia (June 6, 2022) – PharmaCielo Ltd. (“PharmaCielo” or the “Company”) (TSXV:

May 30, 2022 The Company expects Revenue to continue to grow – recently shipped 300 kg of CBD Full Spectrum Oil to a Spanish pharmaceutical company, announced entrance into Polish market, and shipments to Germany expected by late 2022. Steadily building pipeline in other key